CBD Up to 1200mg Daily Failed to Beat Placebo for Alcohol Addiction or PTSD | Research

The takeaway

Two randomized trials found CBD up to 1200mg/day was well-tolerated in actively drinking individuals but showed no superiority over placebo for reducing alcohol consumption, craving, or PTSD symptoms.

People considering CBD for alcohol addiction or PTSD, addiction psychiatrists, and CBD clinical researchers

What the researchers found

Neither trial demonstrated CBD superiority over placebo for drinking outcomes (both groups improved dramatically, Cohen's d>0.9), craving, mood, anxiety, or PTSD symptoms, despite achieving measurable blood levels and acceptable tolerability.

Why it matters

CBD is widely promoted for anxiety, PTSD, and addiction despite limited clinical evidence — these null results from well-designed trials temper expectations and suggest higher doses or different formulations may be needed.

The numbers in context

Study 1: n=27, CBD 600→1200mg/day; Study 2: n=30, CBD 600mg/day; mean trough CBD: 31.15 ng/mL; 22.6% had dose-limiting side effects; both groups improved (Cohen's d>0.9) but CBD≠placebo.

How the study worked

Two simultaneous proof-of-concept RCTs: Study 1 (n=27, AUD only, CBD 600-1200mg/day for 8 weeks) and Study 2 (n=30, AUD+PTSD, CBD 600mg/day for 6 weeks), with pharmacokinetic, safety, and efficacy assessments.

What this study cannot tell us

Small sample sizes (27 and 30); proof-of-concept design not powered for definitive efficacy; achieved CBD blood levels may be insufficient; oral CBD has poor bioavailability.

How to read the evidence

Two randomized placebo-controlled trials with PK data, but small samples and proof-of-concept design mean negative results should be interpreted cautiously.

When this study was published

Published in 2026, providing important negative evidence in a field dominated by positive case reports and preclinical studies.

The bigger picture

The strong placebo response in both trials highlights a fundamental challenge in addiction research — and suggests that the therapeutic context (regular visits, monitoring) may be as important as the pharmacological intervention.

Questions still open

Would higher CBD doses or better bioavailability formulations show efficacy? Is the placebo response in addiction trials an intervention effect in itself?

Common questions

Can CBD help with alcohol addiction?

These two clinical trials found CBD up to 1200mg/day did not reduce drinking more than placebo, though both groups improved substantially. Larger trials with higher doses are needed.

Did CBD help with PTSD symptoms?

No — in the trial of AUD patients with co-occurring PTSD, CBD 600mg/day showed no superiority over placebo for PTSD symptoms, craving, or drinking outcomes.

Read the original research

Effects of cannabidiol in alcohol use disorder patients with and without co-occurring post-traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof-of-concept trials.

Alcohol, clinical & experimental research, 50(1), e70212

View on PubMed ↗Publisher’s paper ↗

Citation

Bogenschutz, Michael P; Blessing, Esther; Dgheim, Danielle; Cho, Dayeon; Zhang, Jun; Laska, Eugene M; Marmar, Charles R. (2026). Effects of cannabidiol in alcohol use disorder patients with and without co-occurring post-traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof-of-concept trials.. Alcohol, clinical & experimental research, 50(1), e70212. https://doi.org/10.1111/acer.70212